Equinor (NYSE: EQNR) reports Q4 results with revenue and production decline, but beats EPS estimate. Plans to strengthen cash flow and increase renewable energy capacity.
GSK's Q4 sales hit $10.40 billion, topping estimates. Specialty Medicines grew 14%, while vaccines declined. The company ...
Palantir surpasses Q4 expectations, easing market concerns about AI investment ROI and showcasing strong growth for the new ...
Palantir is a data analytics and software development company, and has risen dramatically from its market debut in 2020. See ...
"In 2030 expected (oil and gas) production is around 2.2 million barrels of oil equivalent per day, up from a previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results